These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9175239)

  • 1. Absence of factor V Leiden mutation in Koreans.
    Kim YW; Yoon KY; Park S; Shim YS; Cho HI; Park SS
    Thromb Res; 1997 Apr; 86(2):181-2. PubMed ID: 9175239
    [No Abstract]   [Full Text] [Related]  

  • 2. The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals.
    Ko YL; Hsu TS; Wu SM; Ko YS; Chang CJ; Wang SM; Chen WJ; Cheng NJ; Kuo CT; Chiang CW; Lee YS
    Hum Genet; 1996 Aug; 98(2):176-7. PubMed ID: 8698336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of factor V Leiden in Turkey.
    Ozbek U; Tangün Y
    Int J Hematol; 1996 Oct; 64(3-4):291-2. PubMed ID: 8923795
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening.
    Ridker PM; Miletich JP; Hennekens CH; Buring JE
    JAMA; 1997 Apr 23-30; 277(16):1305-7. PubMed ID: 9109469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of activated protein C resistance (factor V Leiden).
    Baker R; Thom J; van Bockxmeer F
    Lancet; 1994 Oct; 344(8930):1162. PubMed ID: 7934522
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor V Leiden prevalence in venous thromboembolism patients.
    Leroyer C; Mercier B; Escoffre M; Férec C; Mottier D
    Chest; 1997 Jun; 111(6):1603-6. PubMed ID: 9187182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
    Bathelier C; Champenois T; Lucotte G
    Mol Cell Probes; 1998 Apr; 12(2):121-3. PubMed ID: 9633048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
    Reuner KH; Litfin F; Patscheke H
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V Leiden mutation investigated by amplification created restriction enzyme site (ACRES) in PNH patients with and without thrombosis.
    Nafa K; Bessler M; Mason P; Vulliamy T; Hillmen P; Castro-Malaspina H; Luzzatto L
    Haematologica; 1996; 81(6):540-2. PubMed ID: 9009443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. World distribution of factor V Leiden.
    Dzimiri N; Meyer B
    Lancet; 1996 Feb; 347(8999):481-2. PubMed ID: 8618525
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombosis, factor V Leiden, and inflammatory bowel disease.
    Shanahan F
    Gastroenterology; 1999 Mar; 116(3):778-9. PubMed ID: 10029640
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase in extreme old age.
    Rees DC; Liu YT; Cox MJ; Elliott P; Wainscoat JS
    Thromb Haemost; 1997 Nov; 78(5):1357-9. PubMed ID: 9408019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The factor V Leiden mutation: spectrum of thrombotic events and laboratory evaluation.
    Bontempo FA; Hassett AC; Faruki H; Steed DL; Webster MW; Makaroun MS
    J Vasc Surg; 1997 Feb; 25(2):271-5; discussion 276. PubMed ID: 9052561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis.
    Dizon-Townson DS; Nelson LM; Jang H; Varner MW; Ward K
    Am J Obstet Gynecol; 1997 Apr; 176(4):883-6. PubMed ID: 9125615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of factor V Leiden mutation in various populations.
    Herrmann FH; Koesling M; Schrŏder W; Altman R; Jiménez Bonilla R; Lopaciuk S; Perez-Requejo JL; Singh JR
    Genet Epidemiol; 1997; 14(4):403-11. PubMed ID: 9271712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World distribution of factor V Leiden.
    Rees DC; Cox M; Clegg JB
    Lancet; 1995 Oct; 346(8983):1133-4. PubMed ID: 7475606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
    Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH
    Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor V Leiden and risks of recurrent idiopathic venous thromboembolism.
    Ridker PM; Miletich JP; Stampfer MJ; Goldhaber SZ; Lindpaintner K; Hennekens CH
    Circulation; 1995 Nov; 92(10):2800-2. PubMed ID: 7586244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan.
    Shen MC; Lin JS; Tsay W
    Thromb Res; 1997 Aug; 87(4):377-85. PubMed ID: 9271815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population study of the G1691A mutation (R506Q, FV Leiden) in the human factor V gene that is associated with resistance to activated protein C.
    Braun A; Müller B; Rosche AA
    Hum Genet; 1996 Feb; 97(2):263-4. PubMed ID: 8566967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.